Leuconostoc species-associated endocarditis

Pharmacotherapy

Volumn 27, Issue 5, 2007, Pages 766-770

  Starr, Jessica A ^a,b  

^a AUBURN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Case report; Endocarditis; Infectious disease; Leuconostoc

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; AORTA VALVE REPLACEMENT; ARTICLE; BLOOD CULTURE; CASE REPORT; CONTINUOUS INFUSION; DEGENERATIVE DISEASE; DRUG WITHDRAWAL; ENDOCARDITIS; GRAM POSITIVE BACTERIUM; HUMAN; LEUCONOSTOC; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING;

ANTI-BACTERIAL AGENTS; AORTIC VALVE; DRUG RESISTANCE, BACTERIAL; ENDOCARDITIS, BACTERIAL; GENTAMICINS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LEUCONOSTOC; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLIN G; VANCOMYCIN;

EID: 34247872906     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.5.766     Document Type: Article

References (21)

1. Garvie EI. Leuconostoc. In: Sneath PHS, Mair NS, Sharpe ME, Holt JG, eds. Bergey's manual of determinative bacteriology, vol 2. Baltimore, MD: Williams and Wilkins, 1986:1071-5.
2. Garvie EI. Separation of species of the genus Leuconostoc and differentiation of the Leuconostoc from other lactic acid bacteria. Methods Microbiol 1984;16:147-78.
3. Facklam R, Elliot JA. Identification, classification, and clinical relevance of catalase-negative, gram-positive cocci, excluding the streptococci and enterococci. Clin Microbiol Rev 1995;8:479-95.
4. Buu-Hoi A, Branger C, Acar JF. Vancomycin-resistant streptococci or Leuconostoc sp. Antimicrob Agents Chemother 1985;28:458-60.
5. Coovadia YM, Solwa Z, van den Ende J. Meningitis caused by vancomycin-resistant Leuconostoc sp. J Clin Microbiol 1987;25:1784-5.
6. Horowitz HW, Handwerger S, Van Horn KG, Wormser GP. Leuconostoc, an emerging pathogen. Lancet 1987;330:1329-30.
7. Coovadia YM, Solwa Z, van den Ende J. Potential pathogenicity of Leuconostoc. Lancet 1988;331:306.
8. Hardy S, Ruoff KL, Catlin EA, Ignacio Santos J. Catheter-associated infection with a vancomycin-resistant gram-positive coccus of the Leuconostoc sp. Pediatr Infect Dis J 1988;7:519-20.
9. Golledge CL. Bactereraia due to Leuconostoc sp. Clin Microbiol Newsletter 1989;11:29-30.
10. Handwerger S, Horowitz H, Coburn K, Kolokathis A, Wormser GP. Infection due to Leuconostoc sp: six cases and review. Rev Infect Dis 1990;12:602-10.
11. Golledge CL. Infection due to Leuconostoc sp. Rev Infect Dis 1191;13:184-5.
12. Vazquez E, Carazo I, Martin A. Infectious endocarditis causes of Leuconostoc mesenteroides [article in Spanish]. Enferm Infecc Microbiol Clin 1998;16:237-8.
13. Cappelli EA, Barros RR, Camello TCF, Teixeira LM, Merquior VL. Leuconostoc pseudomesenteroides as a cause of nosocomial urinary tract infections. J Clin Microbiol 1999;37:4124-6.
14. Scano F, Rossi L, Cattelan A, et al. Leuconostoc species: a case-cluster hospital infection. Scand J Infect Dis 1999;31:371-3.
15. Templin KS, Crook T, Riley T, Whitener C, Aber RC. Spontaneous bacterial peritonitis and bacteremia due to Leuconostoc species in a patient with end-stage liver disease: a case report. J Infect 2001;43:155-7.
16. Isenberg HS, Velloxxi EM, Shapiro J, Rubin LG. Clinical laboratory challenges in the recognition of Leuconostoc spp. J Clin Microbiol 1988;26:479-83.
17. Swenson JM, Facklam RR, Thornsberry C. Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob Agents Chemother 1990;34:543-9.
18. Orberg PK, Sandine WE. Common occurrence of plasmid DNA and vancomycin resistance in Leuconostoc sp. Appl Environ Microbiol 1984;48:1129-33.
19. Ruoff KL, Kuritzkes DR, Wolfson JS, Ferraro MJ. Vancomycin-resistant gram positive bacteria isolated from human sources. J Clin Microbiol 1988;26:2064-8.
20. Golan Y, Poutsiaka DD, Tozzi S, Hadley S, Snydman DR. Daptomycin for line-related Leuconostoc bacteremia. J Antimicrob Chemother 2001;47:364-5.
21. Baddour LM, Wilson WR, Bayer, AS, et al. Infective endocarditis: a statement from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American Heart Association. Circulation 2005;111:2394-e433. Available from http://circ.ahajournals.org/cgi/reprint/111/23/e394.